Phospholipase C (EC 3.1.4.11): A malignancy linked signal transduction enzyme

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1399-1404

  Yang, Hongyuan ^a   Shen, Fei ^a   Herenyiova, Maria ^a   Weber, George ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Enzyme half life; Hepatomas; Phospholipase C; Regenerating liver

Indexed keywords

CYCLOHEXIMIDE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHODIESTERASE; PHOSPHOLIPASE C; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRAIN; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER TRANSPLANTATION; CELL MEMBRANE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME LOCALIZATION; ENZYME SUBSTRATE; HALF LIFE TIME; HEART; KIDNEY CORTEX; LIVER CELL CARCINOMA; LIVER REGENERATION; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SPLEEN; STARVATION; TESTIS; THYMUS;

ANIMALS; BONE MARROW; CELL DIVISION; CYCLOHEXIMIDE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; LIVER REGENERATION; MALE; ORGAN SPECIFICITY; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL-LYASE; PHOSPHOLIPASE C; PHOSPHORIC DIESTER HYDROLASES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS; RATS, INBRED ACI; RATS, INBRED BUF; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 0031876257     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Weber G: Biochemical strategy of cancer cells and the design of chemotherapy: GHA Clowes Memorial Lecture. Cancer Res 43: 3466-3492, 1983.
2. Tricot G, Jayaram HN, Weber G and Huffman R: Tiazofurin: Biological effects and clinical uses. Intl J Cell Cloning 8: 161-170, 1990.
3. Tricot G and Weber G: Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with tiazofurin. A selective blocker of inosine 5'-phosphate dehydrogenase activity. Anticancer Res 16: 3341-3348, 1996.
4. Berridge MJ: Inositol trisphosphate and calcium signaling. Nature 361: 315-325, 1993.
5. Rana RS and Hokin LE: Role of phosphoinositides in transmembrane signaling. Physiol Rev 70: 115-164, 1990.
6. 1. Cancer Res 55: 2978-2980, 1995.
7. Rizzo MT and Weber G: 1-Phosphatidylinositol 4-kinase: An enzyme linked with proliferation and malignancy. Cancer Res 54: 2611-2614, 1994.
8. S Singhal RL, Prajda N, Yeh YA and Weber G: 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): A proliferation- and malignancy-linked signal transduction enzyme. Cancer Res. 54: 5574-5578, 1994.
9. Olah E and Weber G: Giemsa-banding karyotype of rat hepatomas of different growth rates. Cancer Res 39: 1708-1717, 1979.
10. Higgins GM and Anderson RM: Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Path 12: 186-202, 1931.
11. Prajda N, Natsumeda Y, Ikegami T, Reardon MA, Szondy S, Hashimoto Y, Emrani J and Weber G: Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin. Biochem Pharm 37: 875-880, 1988.
12. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochem 72: 248-254, 1976.
13. Rhee SG, Suh PG, Ryu SH and Lee SY: Studies of inositol phospholipid-specific phospholipase C. Sci 244: 546-550, 1989.
14. Cockcroft S and Thomas GMH: Inositol-lipid-specific phospholipase C isozymes and their differential regulation by receptors. Biochem J 288: 1-14, 1992.
15. Melin PM, Sundler R and Jergil B: Phospholipase C in rat liver membranes. Phosphoinositide specificity and regulation by guanine nucleotides and calcium. FEBS Letters 198: 85-88, 1986.
16. Taylor SJ and Exton JH: Guanine-nucleotide and hormone regulation of polyphosphoinositide phospholipase C activity of rat liver plasma membranes. Bivalent cation and phospholipid requirements. Biochem J 248: 791-799, 1987.
17. Rhee SG, Kim H, Suh P-G and Choi WC: Multiple forms of phosphoinositide-specific phospbolipase C and different modes of activation. Intracellular Phospholipases 19: 337-341, 1991.
18. Bresnick E, Williams SS and Mosse H: Rates of turnover of deoxythymidine kinase and its template RNA in regenerating and control liver. Cancer Res 27: 469-475, 1967.
19. Weber G, Prajda N, Yang H, Yeh YA, Shen F, Singhal RL, Herenyiova M and Look KY: Current issues in the regulation of signal transduction. Advan Enzyme Regul 36: 33-55, 1996.
20. Lalwani ND, Hylemon PB and Strom SC: Altered levels of phosphoinositide metabolites and activation of guanine-nucleotide dependent phospholipase C in rat hepatic tumors. J Cell Physiol 147: 354-361, 1991.
21. Homma MK, Homma Y, Namba M and Yuasa Y: Enhanced phosphoinositide metabolism in colorectal carcinoma cells derived from familial adenomatous polyposis patients. J Cell Biochem 55: 477-485, 1994.
22. Nomoto K, Tomita N, Miyake M, Xhu D-B, LoGerfo PR and Weinstein IB: Expression of phospholipase γ1, β1, and δ1 in primary human colon carcinomas and colon carcinoma cell lines. Molec Carcinogenesis 12: 146-152, 1995.
23. Noh D-Y, Lee YH, Kim SS, Kim YI, Ryu S-H, Suh P-G and Park J-G: Elevated content of phospholipase C-γ-1 in colorectal cancer tissues. Cancer 73: 36-41, 1994.
24. Arteaga CL, Johnson MD, Todderud G, Coffey RJ, Carpenter G and Page DL: Elevated content of the tyrosine kinase substrate phospholipase C-γ1 in primary human breast carcinomas. Proc Natl Acad Sci USA 88: 10435-10439, 1991.